• arclein
The findings demonstrate the challenges of developing treatments based on living cells. "Previously, I think many people thought of cell therapy [for Parkinson's] as a dopamine-producing biological pump," says Ole Isacson, a neuroscientist at Harvard Medical School. But in reality, it requires a very specific replacement of nerve cells. Unless you
Watch Streaming Broadcast Live:
LRN.fm
DLive
Live Chat Telegram
Share this page with your friends
on your favorite social network: